Robert Gagnon
Director/Board Member at PURPLE BIOTECH LTD
Net worth: 192 759 $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Eric Rowinsky | M | 67 | 14 years | |
James Green | M | 65 | 9 years | |
Dan Paterson | M | 63 | 13 years | |
Gil Efron | M | 57 | 6 years | |
Daniel Calkins | M | 37 | 6 years | |
Peter Smith | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Caroline Dorsa | F | 64 | 14 years | |
Brian Stuglik | M | 64 | 7 years | |
Jeffrey Frelick | M | 59 | 9 years | |
Michael Kauffman | M | 60 | 12 years | |
Simcha Rock | M | 73 | 11 years | |
Ido Agmon | M | 46 | 8 years | |
Suzana Nahum Zilberberg | F | 53 | 3 years | |
Katherine Eade | F | 50 | 7 years | |
Thomas Loewald | M | 61 | 7 years | |
Michelle Robertson | F | 57 | 3 years | |
Jeffrey A. Duchemin | M | 58 |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | - |
Isaac Israel | M | 44 | 12 years | |
Bruce Stroever | M | 75 | 12 years | |
Stephen Sherwin | M | 75 | 14 years | |
Anil Kapur | M | 54 | 2 years | |
Ori Hershkovitz | M | 49 | 3 years | |
Paul Bunn | M | 79 | 3 years | |
Yael Margolin | M | 70 | 1 years | |
Lior Fhima | M | - | 2 years | |
Michael Schickler | M | 55 | 4 years | |
Cathy Carew | F | - | - | |
Bertrand Loy | M | 58 | 10 years | |
John Johnson | M | 66 | 4 years | |
Siddhesh Angle | M | 39 | - | |
Kristina Burrow | F | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | 39 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Michael Rome | M | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Ido Morpurgo | M | 51 | 4 years | |
Michael Dambach | M | 57 | 17 years | |
Hagop Youssoufian | M | 67 | 7 years | |
Karin Tollefson | M | 57 | 1 years | |
Yisrael Gewirtz | M | 47 | 8 years | |
Deina Walsh | F | 60 | 10 years | |
William Berlin | M | - | - | |
Scott Biller | M | 68 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 4 years |
Jonathan Pachter | M | 66 | 13 years | |
David Mitchell | M | 67 | 1 years | |
Don Hankey | M | 81 | 6 years | |
Leon E. Chen | M | 49 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | - |
Hadas Reuveni | M | 56 | 7 years | |
Bertrand C. Liang | M | 61 | 4 years | |
J. Goater | M | 48 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 1 years |
Matt Patterson | M | 52 |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | 3 years |
Michael Crowther | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert M. Forrester | M | 60 | 8 years | |
Gina Consylman | F | 52 | 7 years | |
Joseph Chiapponi | M | 55 | 6 years | |
Susan M. Luscinski | F | 67 | 28 years | |
Stelios Papadopoulos | M | 75 | 15 years | |
Thomas McNaughton | M | 63 | 5 years | |
William Rastetter | M | 76 | 19 years | |
James Mullen | M | 65 | 21 years | |
David Green | M | 60 | 21 years | |
Earl Lewis | M | 80 | 18 years | |
George Uveges | M | 76 | 12 years | |
Brian Sullivan | M | - | 9 years | |
Samantha Truex | F | - | 8 years | |
Trevor Anthony Mill | M | 53 | 9 years | |
Revital Stern-Raff | M | 50 | 4 years | |
Lynne Sullivan | F | 58 | 10 years | |
Alison Lawton | F | 62 | 8 years | |
Sean Flynn | M | 50 | 1 years | |
John Doyle | M | 46 | 2 years | |
Carlos Costa | M | 51 | 7 years | |
Joseph Mara | M | 49 | - | |
Peter A. Pellegrino | M | 49 | 1 years | |
Madelyn Zeylikman | F | - | - | |
Nir Livneh | M | 45 | - | |
Lesley Solomon | F | 52 | 2 years | |
Eric S. Hoffman | M | 54 | 5 years | |
Richard Mulligan | M | 69 | 14 years | |
S. Phanstiel | F | 65 | 6 years | |
Craig Eric Schneier | M | 76 | 8 years | |
Robert A. Hamm | M | 72 | 7 years | |
Neal J. Harte | M | 79 | 12 years | |
Gregory Covino | M | 59 | 6 years | |
Michael Gilman | M | 69 | 8 years | |
Robert A. Dishman | M | 79 | 15 years | |
Alexander Denner | M | 54 | 14 years | |
Brian Posner | M | 62 | 14 years | |
George Scangos | M | 76 | 7 years | |
Timothy Barberich | M | 76 | 8 years | |
Nancy L. Leaming | F | 76 | 14 years | |
Phillip Sharp | M | 79 | 31 years | |
Bruce Wendel | M | 70 | 5 years | |
Cecilia Jones | F | 49 | - | |
Marc Schegerin | M | 48 | 4 years | |
Mary L. Good | M | 93 | 10 years | |
Mary DiBiase | M | 63 | 16 years | |
Brendan Reidy | M | 46 | 7 years | |
Michael Panzara | M | 57 | 8 years | |
A. Sanders | F | 60 | 6 years | |
Daniel Char | M | 63 | 11 years | |
David W Miller | M | - | 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 79 | 79.00% |
Israel | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Gagnon
- Personal Network